3.88MMarket Cap-0.37P/E (TTM)
0.650High0.562Low166.80KVolume0.646Open0.653Pre Close107.51KTurnover10.51%Turnover RatioLossP/E (Static)6.03MShares6.00052wk High-2.72P/B1.02MFloat Cap0.45052wk Low--Dividend TTM1.59MShs Float6.000Historical High--Div YieldTTM13.48%Amplitude0.450Historical Low0.644Avg Price1Lot Size
Channel Therapeutics Stock Forum
📊⚡️📊
📊⚡️📊
Benzinga· 2 mins ago
Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain
Chromocell Therapeutics (NYSE American: CHRO) has unveiled an injectable depot program using peripheral nerve blocks for post-operative pain treatment. The program leverages the company's NaV1.7 molecule, targeting a market of approximately 700,000 total knee replacements and 500,000 shoulder arthroplastiesperformed annually in the US. The company's drug has shown...
looking good for a decent run maybe 🤞
something brewing here maybe?
No comment yet